Evaluate the pain relief produced by neural blockade of nerves in the serratus anterior muscle plane in patients undergoing minimally invasive coronary artery bypass surgery
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: null- Patient scheduled for MIDCAB surgery under general anesthesia
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (35-65 yrs) of either sex, American society of Anesthesiologists (ASA) physical status I and II with New York Heart association (NYHA) grading I and II, scheduled for MIDCAB surgery under general anesthesia will be included in the study.
Exclusion Criteria
Patients with uncontrolled medical diseases, uncontrolled psychiatric ailments, coagulopathy, infection at the local site and patient refusal.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pain relief from serratus anterior plane blocks in MIDCAB surgery?
How does serratus anterior plane block compare to standard analgesic regimens in post-MIDCAB pain management?
Are there specific biomarkers that predict optimal response to serratus anterior plane nerve blocks in cardiac surgery?
What are the potential adverse events associated with serratus anterior plane blocks in coronary bypass patients?
How do regional anesthetic techniques like SAPB integrate with multimodal analgesia in minimally invasive cardiac surgery?